Core Points - The stock price of Huatai Medical (688617) increased by 1.22% to 295.0 CNY as of July 11, 2025, with a market capitalization of 41.599 billion CNY, ranking 4th in the medical device sector [1] - The company held its 23rd meeting of the second board of directors on July 7, 2025, where several key resolutions were passed, including changes to registered capital and amendments to the company's articles of association [1][5] - Huatai Medical plans to distribute a cash dividend of 17.50 CNY per 10 shares and to increase capital by 4.5 shares for every 10 shares held, resulting in a total share count increase to 141,013,796 shares [1][5] Company Announcements - The company announced the abandonment of part of its preemptive rights and plans to increase capital by 50 million CNY in its subsidiary, Yiweidi, which focuses on non-vascular interventional business [2][5] - The board approved adjustments to the 2021 restricted stock incentive plan, including changes to grant prices and quantities due to management's request to defer stock vesting [3][5] - The adjustments include a reduction in the grant price for A-class restricted stock from 137.68 CNY to 93.74 CNY and for B-class restricted stock from 123.56 CNY to 84.01 CNY [3]

Core Viewpoint - The company has decided to cancel its supervisory board, change its registered capital, and amend its articles of association, which will be submitted for approval at the upcoming extraordinary general meeting of shareholders [1][2]. Summary by Sections Cancellation of Supervisory Board - The company will no longer have a supervisory board, with its functions transferred to the audit committee of the board of directors. Relevant rules and regulations concerning the supervisory board will be abolished [1][2]. Change in Registered Capital - The company has completed the first grant of the 2020 stock option incentive plan and the fourth exercise period, resulting in a total share registration of 1,191,275 shares. Following this, the total share capital of the company has been adjusted [2]. Amendments to Articles of Association - The company plans to amend several provisions in its articles of association to enhance governance and comply with relevant laws and regulations. Key changes include the uniform modification of "shareholders' meeting" to "shareholders' assembly" and the removal of references to the supervisory board [2][3]. Revision and Formulation of Corporate Governance Systems - The company aims to revise and establish certain corporate governance systems to promote standardized operations and improve internal governance mechanisms. These revisions have been approved by the board of directors and will require shareholder approval to take effect [3][4]. Disclosure of Revised Articles - The full text of the revised articles of association and the related governance systems will be disclosed on the Shanghai Stock Exchange website [4].

Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss changes to its name, registered address, registered capital, and amendments to the Articles of Association [1][6] - The meeting will ensure the protection of shareholders' rights and maintain order and efficiency during the proceedings [1][2] Meeting Procedures - Only shareholders, their proxies, directors, supervisors, and other relevant personnel are allowed to attend the meeting, with the company having the right to refuse entry to others [2] - Shareholders and their proxies have the right to speak, inquire, and vote during the meeting, and must register their questions in advance [3][4] - Voting will be conducted through a combination of on-site and online methods, with results announced after counting [4][6] Proposed Changes - The company plans to change its name from "Guangdong Tiancheng Technology Co., Ltd." to "Shanghai Tiancheng Technology Co., Ltd." and increase its registered capital from RMB 83.957192 million to RMB 124.724524 million [8][9] - The registered address will also change to a new location in the Shanghai Free Trade Zone [8] - The amendments to the Articles of Association are necessary to align with the new name, address, and capital structure, while ensuring compliance with relevant laws and regulations [9]

PAN-CHINA Certifie d Public Accountants 浙江圣达生物药业股份有限公司 天健会计师 事务 所 Pan-China Certified Public Accountants | 目 录 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | ………………………………………………………… 一、验资报告 | 1—2 | | | | 页 | | | 第 | | 二、附件 | | | | | 页 | | | ………………………………………………………………第 3—13 | | （一）注册资本及实收股本变更前后对照表 | | | | | | 页 | | ………………………第 3 | | （二）验资事项说明 …………………………………………… | | | | | | 页 | | 第 4—5 | | （三）银行收款单和询证函复印件…………………………… 第 | | | | 页 | | | | 6—8 | | （五）本所执业证书复印件 ……………………………………… | | | | | | 页 ...

Group 1 - The company has approved a change in registered capital and corresponding amendments to its Articles of Association due to the implementation of the 2024 profit distribution plan and the conversion of convertible bonds into shares [1][2] - The registered capital will be increased from RMB 3,014,978,914 to RMB 3,316,485,099 as a result of the conversion of 52,000 yuan of convertible bonds into 7,540 shares [1][2] - The company plans to modify the relevant clauses in its Articles of Association to reflect the new registered capital amount, while other provisions will remain unchanged [2]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss a proposal regarding changes to registered capital and amendments to the Articles of Association [1][5][7] - The meeting will ensure the protection of shareholders' rights and maintain order during the proceedings [2][4] Meeting Procedures - Attendees must register and confirm their participation before the meeting starts, and latecomers will not be allowed to register [2][4] - Shareholders have the right to speak, inquire, and vote during the meeting, but must adhere to specific guidelines to maintain order [2][3] - Voting will be conducted through both on-site and online methods, with specific time frames for each [4][5] Agenda Items - The main agenda item is the proposal to change the registered capital from RMB 158,419,873 to RMB 205,674,335, which includes a capital increase of 47,254,462 shares [6][7] - The proposal requires a special resolution, needing approval from more than two-thirds of the voting rights held by attending shareholders [7]

Core Viewpoint - Shenzhen Longke Intelligent Electric Co., Ltd. has announced changes to its registered capital and amendments to its articles of association following the approval from the China Securities Regulatory Commission for the issuance of convertible bonds [1][2]. Summary by Sections Changes to Registered Capital - The company has changed its registered capital from RMB 268,127,372 to RMB 306,371,334, reflecting the conversion of 3,781,730 convertible bonds into 38,268,831 shares [2][4]. Amendments to Articles of Association - The amendments include updates to various articles to comply with the revised regulations of the Shenzhen Stock Exchange and to reflect the company's actual situation [2][3]. - Specific changes include the definition of the legal representative and the responsibilities associated with it, as well as the rights and obligations of shareholders [3][4]. Authorization for Business Registration Changes - The board of directors has requested authorization from the shareholders' meeting to handle the business registration changes and related documentation, with the authorization valid until the completion of the registration process [2][3].

关于变更注册资本及修订《公司章程》并办理工 商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 优利德科技（中国）股份有限公司（以下简称"公司"）于 2025 年 6 月 4 日召开第三届董事会第十次会议，审议通过了《关于变更注册资本及修订 <公司> 章程>并办理工商变更登记的议案》。现将有关情况公告如下： 证券代码：688628 证券简称：优利德 公告编号：2025-027 优利德科技（中国）股份有限公司 第二十条 公司股份总数为 第二十条 公司股份总数为 除上述修订的条款外，《公司章程》其他条款保持不变, 上述变更最终以工 商登记机关核准的内容为准，修订后的《公司章程》同日在上海证券交易所网站 （www.sse.com.cn）予以披露。 结合上述变更及实际情况，公司对《公司章程》相应条款进行修订，具体修 订内容如下： 一、变更注册资本情况 序号 修订前 修订后 次激励计划"）首次授予部分第三个归属期及预留授予部分第二个归属期的股份 登记工作，新增股份 49.9051 万股。 上述股份登记手续完成后，公司总股 ...

Group 1 - The company held its 11th meeting of the 3rd Board of Directors on May 30, 2025, with all 7 directors present, ensuring compliance with legal and regulatory requirements [1][2] - The Board approved a proposal to expand the business scope to include "inspection and testing services" to meet operational needs [1][2] - As of May 29, 2025, the company's total share capital increased from 400,865,155 shares to 401,317,665 shares due to the conversion of convertible bonds, leading to a corresponding increase in registered capital [1][2] Group 2 - The proposal requires approval from the shareholders' meeting, needing a two-thirds majority of the voting rights present [2] - The company plans to hold its first extraordinary shareholders' meeting of 2025 on June 16, 2025, to discuss the proposal [2]

Group 1 - The company, Shanghai Baolong Automotive Technology Co., Ltd., has announced a reduction in registered capital and amendments to its Articles of Association, which requires shareholder approval [1][2] - The board of directors approved the repurchase and cancellation of 859,750 restricted shares at a price of 28.20 RMB per share due to performance assessment not meeting targets [1][2] - Following the repurchase, the total share capital will decrease from 214,479,582 shares to 213,619,832 shares, and the registered capital will reduce from 214,479,582 RMB to 213,619,832 RMB [1][2] Group 2 - The company will amend specific clauses in its Articles of Association to reflect the changes in registered capital and total shares [2] - The revised Articles of Association will be disclosed on the Shanghai Stock Exchange and other designated media [2] - The board has requested the shareholders' meeting to authorize management to handle the necessary business registration changes [2]